Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- Check6 days agoChange DetectedA minor version update was added (Revision: v3.4.2) and older notices including Revision: v3.4.1 were removed. These appear to be routine site maintenance and do not modify the study information.SummaryDifference0.5%

- Check14 days agoChange DetectedA government funding notice has been added at the top of the page, noting status updates for the NIH Clinical Center, and the page revision has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange Detected- The page now shows a glossary and includes minor metadata text updates (e.g., revision/version labels). These changes do not modify study data or how users interact with the page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page displays Revision: v3.3.4, replacing the previous v3.3.3. This is a metadata update and does not change the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check56 days agoChange DetectedFooter text updated: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 is now displayed in the page footer, replacing v3.2.0. There are no changes to study content, eligibility criteria, endpoints, or other substantive content.SummaryDifference0.1%

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.